首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   938730篇
  免费   67121篇
  国内免费   2329篇
耳鼻咽喉   11827篇
儿科学   29383篇
妇产科学   22001篇
基础医学   141058篇
口腔科学   24310篇
临床医学   87179篇
内科学   183231篇
皮肤病学   19335篇
神经病学   72303篇
特种医学   33605篇
外国民族医学   87篇
外科学   140478篇
综合类   18064篇
现状与发展   2篇
一般理论   470篇
预防医学   71322篇
眼科学   22509篇
药学   70028篇
  7篇
中国医学   2690篇
肿瘤学   58291篇
  2021年   10267篇
  2019年   10391篇
  2018年   13432篇
  2017年   10269篇
  2016年   11469篇
  2015年   12994篇
  2014年   18381篇
  2013年   26566篇
  2012年   37418篇
  2011年   39275篇
  2010年   22711篇
  2009年   20863篇
  2008年   35646篇
  2007年   38011篇
  2006年   38325篇
  2005年   36855篇
  2004年   35358篇
  2003年   33236篇
  2002年   31783篇
  2001年   38316篇
  2000年   38410篇
  1999年   32576篇
  1998年   10780篇
  1997年   9092篇
  1996年   9043篇
  1995年   8533篇
  1994年   7707篇
  1993年   7032篇
  1992年   24122篇
  1991年   23994篇
  1990年   23253篇
  1989年   22987篇
  1988年   20921篇
  1987年   20306篇
  1986年   19349篇
  1985年   18201篇
  1984年   13812篇
  1983年   11794篇
  1982年   7166篇
  1981年   6484篇
  1979年   12158篇
  1978年   8830篇
  1977年   7406篇
  1976年   7137篇
  1975年   7693篇
  1974年   8933篇
  1973年   8498篇
  1972年   7987篇
  1971年   7381篇
  1970年   7098篇
排序方式: 共有10000条查询结果,搜索用时 468 毫秒
31.
32.
Bulletin of Experimental Biology and Medicine - Ammonium, an end-product of catabolism, in low doses can promote adaptation of metabolic pathways in erythrocytes under conditions of extreme...  相似文献   
33.
34.
35.
36.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
37.
38.
39.
We report two British cases of liver abscess, due to Klebsiella pneumoniae and associated with synchronous infection elsewhere, which required liver resection for definitive treatment. They illustrate the geographic spread of aggressive K pneumoniae liver infection and demonstrate the importance of early aggressive treatment.  相似文献   
40.
Owing to the frequent incidence of blast-induced traumatic brain injury (bTBI) in recent military conflicts, there is an urgent need to develop effective therapies for bTBI-related pathologies. Blood-brain barrier (BBB) breakdown has been reported to occur after primary blast exposure, making restoration of BBB function and integrity a promising therapeutic target. We tested the hypothesis that treatment with dexamethasone (DEX) after primary blast injury potentiates recovery of an in vitro BBB model consisting of mouse brain endothelial cells (bEnd.3). DEX treatment resulted in complete recovery of transendothelial electrical resistance and hydraulic conductivity 1 day after injury, compared with 3 days for vehicle-treated injured cultures. Administration of RU486 (mifepristone) inhibited effects of DEX, confirming that barrier restoration was mediated by glucocorticoid receptor signaling. Potentiated recovery with DEX treatment was accompanied by stronger zonula occludens (ZO)-1 tight junction immunostaining and expression, suggesting that increased ZO-1 expression was a structural correlate to BBB recovery after blast. Interestingly, augmented ZO-1 protein expression was associated with specific upregulation of the α+ isoform but not the α isoform. This is the first study to provide a mechanistic basis for potentiated functional recovery of an in vitro BBB model because of glucocorticoid treatment after primary blast injury.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号